These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 35713329)
1. Tailored Phenyl Esters Inhibit ClpXP and Attenuate Staphylococcus aureus α-Hemolysin Secretion. Schwarz M; Hübner I; Sieber SA Chembiochem; 2022 Aug; 23(16):e202200253. PubMed ID: 35713329 [TBL] [Abstract][Full Text] [Related]
2. Tailored Peptide Phenyl Esters Block ClpXP Proteolysis by an Unusual Breakdown into a Heptamer-Hexamer Assembly. Lakemeyer M; Bertosin E; Möller F; Balogh D; Strasser R; Dietz H; Sieber SA Angew Chem Int Ed Engl; 2019 May; 58(21):7127-7132. PubMed ID: 30829431 [TBL] [Abstract][Full Text] [Related]
3. Phenyl Esters Are Potent Inhibitors of Caseinolytic Protease P and Reveal a Stereogenic Switch for Deoligomerization. Hackl MW; Lakemeyer M; Dahmen M; Glaser M; Pahl A; Lorenz-Baath K; Menzel T; Sievers S; Böttcher T; Antes I; Waldmann H; Sieber SA J Am Chem Soc; 2015 Jul; 137(26):8475-83. PubMed ID: 26083639 [TBL] [Abstract][Full Text] [Related]
4. High-Throughput Screening Strategies for the Development of Anti-Virulence Inhibitors Against Staphylococcus aureus. Cai X; Zheng W; Li Z Curr Med Chem; 2019; 26(13):2297-2312. PubMed ID: 29165063 [TBL] [Abstract][Full Text] [Related]
6. Suppression of Gao P; Ho PL; Yan B; Sze KH; Davies J; Kao RYT Proc Natl Acad Sci U S A; 2018 Jul; 115(31):8003-8008. PubMed ID: 30012613 [TBL] [Abstract][Full Text] [Related]
7. A Chemical Disruptor of the ClpX Chaperone Complex Attenuates the Virulence of Multidrug-Resistant Staphylococcus aureus. Fetzer C; Korotkov VS; Thänert R; Lee KM; Neuenschwander M; von Kries JP; Medina E; Sieber SA Angew Chem Int Ed Engl; 2017 Dec; 56(49):15746-15750. PubMed ID: 28906057 [TBL] [Abstract][Full Text] [Related]
8. Beta-lactones as specific inhibitors of ClpP attenuate the production of extracellular virulence factors of Staphylococcus aureus. Böttcher T; Sieber SA J Am Chem Soc; 2008 Nov; 130(44):14400-1. PubMed ID: 18847196 [TBL] [Abstract][Full Text] [Related]
9. The ClpXP protease is dispensable for degradation of unfolded proteins in Staphylococcus aureus. Stahlhut SG; Alqarzaee AA; Jensen C; Fisker NS; Pereira AR; Pinho MG; Thomas VC; Frees D Sci Rep; 2017 Sep; 7(1):11739. PubMed ID: 28924169 [TBL] [Abstract][Full Text] [Related]
11. The ClpXP Protease Contributes to Staphylococcus aureus Pneumonia. Kim GL; Akoolo L; Parker D J Infect Dis; 2020 Sep; 222(8):1400-1404. PubMed ID: 32386322 [TBL] [Abstract][Full Text] [Related]
12. Development and characterization of improved β-lactone-based anti-virulence drugs targeting ClpP. Zeiler E; Korotkov VS; Lorenz-Baath K; Böttcher T; Sieber SA Bioorg Med Chem; 2012 Jan; 20(2):583-91. PubMed ID: 21855356 [TBL] [Abstract][Full Text] [Related]
13. Alternative roles of ClpX and ClpP in Staphylococcus aureus stress tolerance and virulence. Frees D; Qazi SN; Hill PJ; Ingmer H Mol Microbiol; 2003 Jun; 48(6):1565-78. PubMed ID: 12791139 [TBL] [Abstract][Full Text] [Related]
14. Quantitative Map of β-Lactone-Induced Virulence Regulation. Krysiak J; Stahl M; Vomacka J; Fetzer C; Lakemeyer M; Fux A; Sieber SA J Proteome Res; 2017 Mar; 16(3):1180-1192. PubMed ID: 28186774 [TBL] [Abstract][Full Text] [Related]
15. Ureadepsipeptides as ClpP Activators. Griffith EC; Zhao Y; Singh AP; Conlon BP; Tangallapally R; Shadrick WR; Liu J; Wallace MJ; Yang L; Elmore JM; Li Y; Zheng Z; Miller DJ; Cheramie MN; Lee RB; LaFleur MD; Lewis K; Lee RE ACS Infect Dis; 2019 Nov; 5(11):1915-1925. PubMed ID: 31588734 [TBL] [Abstract][Full Text] [Related]
16. Subinhibitory concentrations of resveratrol reduce alpha-hemolysin production in Staphylococcus aureus isolates by downregulating saeRS. Duan J; Li M; Hao Z; Shen X; Liu L; Jin Y; Wang S; Guo Y; Yang L; Wang L; Yu F Emerg Microbes Infect; 2018 Jul; 7(1):136. PubMed ID: 30065273 [TBL] [Abstract][Full Text] [Related]
17. ClpXP protease regulates the type III secretion system of Dickeya dadantii 3937 and is essential for the bacterial virulence. Li Y; Yamazaki A; Zou L; Biddle E; Zeng Q; Wang Y; Lin H; Wang Q; Yang CH Mol Plant Microbe Interact; 2010 Jul; 23(7):871-8. PubMed ID: 20521950 [TBL] [Abstract][Full Text] [Related]
18. Discovery of Novel Peptidomimetic Boronate ClpP Inhibitors with Noncanonical Enzyme Mechanism as Potent Virulence Blockers Ju Y; He L; Zhou Y; Yang T; Sun K; Song R; Yang Y; Li C; Sang Z; Bao R; Luo Y J Med Chem; 2020 Mar; 63(6):3104-3119. PubMed ID: 32031798 [TBL] [Abstract][Full Text] [Related]
19. The development of small-molecule modulators for ClpP protease activity. Ye F; Li J; Yang CG Mol Biosyst; 2016 Dec; 13(1):23-31. PubMed ID: 27831584 [TBL] [Abstract][Full Text] [Related]
20. Myricetin protects mice against MRSA-related lethal pneumonia by targeting ClpP. Jing S; Wang L; Wang T; Fan L; Chen L; Xiang H; Shi Y; Wang D Biochem Pharmacol; 2021 Oct; 192():114753. PubMed ID: 34474040 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]